# Citation Standards

Consistent citation format for regulatory documentation to ensure traceability and verifiability.

## General Citation Principles

### Mandatory Citation Elements

Every regulatory claim MUST include:

1. **Source Name**: Full official name of regulation, standard, or document
2. **Section/Article Identifier**: Specific section, article, or clause number
3. **Version/Date**: Publication year, revision date, or effective date
4. **Requirement Text**: Direct quote or accurate paraphrase with attribution

### Citation Placement

- **Inline Citation**: Place citation immediately after claim in parentheses
- **Footnote Citation**: Use footnotes for supplementary citations
- **Reference Section**: List all sources in dedicated References section
- **Traceability Matrix**: Link requirements to source citations in matrix

---

## Regulatory Citation Formats

### FDA Regulations (21 CFR)

**Format:**
```
[Title] [CFR Part].[Section] ([Topic]): "[Requirement text]"
```

**Examples:**

```
21 CFR Part 820.30 (Design Controls): "Each manufacturer shall establish and maintain procedures to control the design of the device to ensure that specified design requirements are met."

21 CFR 820.75 (Process Validation): "Where the results of a process cannot be fully verified by subsequent inspection and test, the process shall be validated with a high degree of assurance."

FDA 21 CFR 814.20 (PMA Application): "A PMA shall include valid scientific evidence from well-controlled investigations."
```

**Inline Citation Style:**
```
Design controls must be established to ensure specified requirements are met (21 CFR 820.30).
```

### EU MDR (Regulation 2017/745)

**Format:**
```
[Regulation] (EU) [Number]/[Year], Article [X]([paragraph]): "[Requirement text]"
```

**Examples:**

```
Regulation (EU) 2017/745, Article 10(9): "Devices shall be designed and manufactured in such a way as to remove or reduce as far as possible the risk of infection to patients, users and where applicable, other persons."

EU MDR 2017/745, Annex I Section 5.1: "Devices shall achieve the performance intended by their manufacturer and shall be designed and manufactured in such a way that, during normal conditions of use, they are suitable for their intended purpose."

EU MDR, Article 61(1): "Economic operators shall demonstrate conformity of their devices with the requirements of this Regulation by following the relevant conformity assessment procedures."
```

**Inline Citation Style:**
```
Devices must achieve intended performance during normal use conditions (EU MDR 2017/745, Annex I Section 5.1).
```

### MFDS Regulations (Korea)

**Format:**
```
[Regulation Name in English] ([Korean Name]), Article [X]: "[Requirement text]"
```

**Examples:**

```
Medical Device Act (의료기기법), Article 6: "No person shall manufacture or import a medical device without obtaining approval from the Minister of Food and Drug Safety."

Regulations on Safety and Performance of Medical Devices (의료기기의 안전성 및 성능에 관한 기준), Article 15: "Medical devices shall be designed and manufactured to minimize risks."
```

**Inline Citation Style:**
```
Manufacturing requires MFDS approval (Medical Device Act, Article 6).
```

---

## Standards Citation Formats

### ISO Standards

**Format:**
```
ISO [Number]:[Year], Section [X.Y] ([Topic]): "[Requirement text]"
```

**Examples:**

```
ISO 13485:2016, Section 7.3.2 (Design and development inputs): "Inputs relating to product requirements shall be determined and records maintained."

ISO 13485:2016, Clause 8.2.4 (Monitoring and measurement of product): "The organization shall monitor and measure the characteristics of the product to verify that product requirements have been met."

ISO 14971:2019, Section 5.3 (Risk analysis): "For each identified hazardous situation, the manufacturer shall estimate the associated risk(s) using available information or data."
```

**Inline Citation Style:**
```
Design inputs must be determined and documented (ISO 13485:2016, Section 7.3.2).
```

### IEC Standards

**Format:**
```
IEC [Number]:[Year], Section [X.Y] ([Topic]): "[Requirement text]"
```

**Examples:**

```
IEC 62304:2006+AMD1:2015, Section 5.1.1 (Software development plan): "The manufacturer shall define or reference the software development life cycle model to be used."

IEC 62366-1:2015, Section 5.1 (User interface specification): "The manufacturer shall specify the user interface in a manner that enables design verification and validation."

IEC 60601-1:2005+AMD1:2012, Section 4.2 (General requirements): "Medical electrical equipment shall be designed and manufactured such that when used under normal conditions and in single fault condition, the risks are acceptable."
```

**Inline Citation Style:**
```
Software development lifecycle must be defined (IEC 62304:2006+AMD1:2015, Section 5.1.1).
```

### Harmonized Standards (EU)

When citing harmonized standards for EU MDR compliance, add harmonization reference:

**Format:**
```
[Standard Citation] (Harmonized under EU MDR 2017/745, [OJ Reference])
```

**Example:**
```
ISO 13485:2016 (Harmonized under EU MDR 2017/745, OJ C 166, 10.5.2022, p. 1)
```

---

## Guidance Document Citation Formats

### FDA Guidance Documents

**Format:**
```
FDA, "[Guidance Title]", [Month] [Year]: "[Excerpt]"
```

**Examples:**

```
FDA, "Deciding When to Submit a 510(k) for a Change to an Existing Device", October 2017: "Manufacturers should submit a new 510(k) when the device, its materials, or its principles of operation have changed such that the safety or effectiveness of the device may be affected."

FDA, "Content of Premarket Submissions for Management of Cybersecurity in Medical Devices", October 2014: "Manufacturers should consider cybersecurity throughout the total product life cycle."
```

**Inline Citation Style:**
```
Cybersecurity must be considered throughout product lifecycle (FDA Guidance, "Content of Premarket Submissions for Cybersecurity", October 2014).
```

### EU MDCG Guidance

**Format:**
```
MDCG [Year]-[Number], "[Guidance Title]", [Month] [Year]: "[Excerpt]"
```

**Examples:**

```
MDCG 2019-11, "Guidance on Qualification and Classification of Software", October 2019: "Medical device software includes software that is intended to be used, alone or in combination, for a purpose as specified in the definition of a 'medical device' in the MDR."

MDCG 2020-1, "Guidance on Clinical Evaluation", March 2020: "Clinical evaluation is an ongoing process throughout the lifetime of the device."
```

**Inline Citation Style:**
```
Clinical evaluation continues throughout device lifetime (MDCG 2020-1, March 2020).
```

### Notified Body Guidance

**Format:**
```
[Notified Body Name], "[Document Title]", [Version], [Date]: "[Excerpt]"
```

**Example:**
```
TÜV SÜD, "Technical Documentation Requirements for Medical Devices", Version 2.1, January 2023: "Technical documentation must demonstrate conformity with applicable requirements."
```

---

## Clinical Literature Citation Formats

### Journal Articles

**Format (AMA Style):**
```
[Authors]. [Article Title]. [Journal Name]. [Year];[Volume]([Issue]):[Pages].
```

**Examples:**

```
Smith JD, Johnson AB, Lee CD. Safety and efficacy of novel cardiac stent design: a randomized controlled trial. J Am Coll Cardiol. 2023;81(12):1234-1245.

Chen W, Garcia M, Patel R, et al. Long-term outcomes of implantable cardioverter-defibrillators: systematic review and meta-analysis. Circulation. 2022;145(8):678-691.
```

**Inline Citation Style:**
```
Clinical data demonstrate safety and efficacy of the stent design (Smith et al, J Am Coll Cardiol 2023).
```

### Clinical Trial Registry

**Format:**
```
ClinicalTrials.gov Identifier: [NCT Number]. [Study Title]. [Last Updated Date].
```

**Example:**
```
ClinicalTrials.gov Identifier: NCT04567890. Evaluation of Novel Insulin Pump in Type 1 Diabetes. Last updated: January 15, 2024.
```

---

## Predicate Device Citation Formats

### FDA 510(k) Clearance

**Format:**
```
FDA 510(k) [Number], [Device Name], [Applicant], cleared [Month] [Year].
```

**Examples:**

```
FDA 510(k) K123456, "CardioMonitor Pro", MedDevice Corp., cleared March 2022.

510(k) K234567, XYZ Infusion Pump, cleared February 2021, demonstrates substantial equivalence for flow rate accuracy.
```

**Inline Citation Style:**
```
The predicate device (510(k) K123456) has equivalent technological characteristics.
```

### FDA PMA Approval

**Format:**
```
FDA PMA [Number], [Device Name], [Applicant], approved [Month] [Year].
```

**Example:**
```
FDA PMA P210045, "HeartAssist Ventricular Device", CardioTech Inc., approved November 2023.
```

---

## Traceability Matrix Format

Link requirements to source citations in tabular format:

| Requirement ID | Requirement Text | Source Citation | Section/Clause | Verification Method |
|---------------|------------------|-----------------|----------------|---------------------|
| REQ-001 | Device shall meet design inputs | ISO 13485:2016 | 7.3.2 | Design review |
| REQ-002 | Risk analysis required | ISO 14971:2019 | 5.3 | Risk management file |
| REQ-003 | Software development plan | IEC 62304:2006+AMD1:2015 | 5.1.1 | SDP document |

---

## Version Control and Currency

### Indicating Current Version

Always cite current effective version with date:

```
ISO 13485:2016 (current as of 2026-02-09)
FDA 21 CFR 820 (as amended, effective 2026-02-09)
EU MDR 2017/745 (in force from May 26, 2021)
```

### Superseded Standards

When citing superseded standards (for historical context):

```
ISO 13485:2003 (superseded by ISO 13485:2016)
```

### Amendments and Corrigenda

**Format:**
```
[Standard]:[Year]+AMD[Number]:[Year] or [Standard]:[Year]/COR[Number]:[Year]
```

**Examples:**
```
IEC 62304:2006+AMD1:2015 (includes Amendment 1)
ISO 14971:2019/COR1:2020 (includes Corrigendum 1)
```

---

## Citation Verification Checklist

Before finalizing any document with citations:

- [ ] All regulatory claims have complete citations
- [ ] Standard format used consistently for each source type
- [ ] Current effective versions cited (verified via Context7)
- [ ] Section/article numbers accurate
- [ ] Requirement text accurately quoted or paraphrased
- [ ] Traceability matrix links requirements to citations
- [ ] Citations are verifiable (sources accessible to reviewers)
- [ ] Version dates included for all standards
- [ ] Amendments or corrigenda noted where applicable
- [ ] References section includes all cited sources

---

## Common Citation Errors to Avoid

**Incomplete Citation:**
- Wrong: "ISO 13485 requires design controls."
- Correct: "ISO 13485:2016, Section 7.3 requires design controls."

**Outdated Version:**
- Wrong: "ISO 13485:2003 requires..." (when 2016 version is current)
- Correct: "ISO 13485:2016 requires..."

**Missing Section Identifier:**
- Wrong: "21 CFR 820 requires process validation."
- Correct: "21 CFR 820.75 requires process validation."

**Inaccurate Paraphrase:**
- Wrong: Changing meaning when paraphrasing requirement text
- Correct: Direct quote or accurate paraphrase with citation

**Unverifiable Source:**
- Wrong: Citing consultant interpretation as regulation
- Correct: Cite original regulation, note interpretation separately

---

Version: 1.0.0
Last Updated: 2026-02-09
